Deepali Malhotra

Title: Deepali Malhotra: Innovator in Biopharmaceuticals

Introduction

Deepali Malhotra is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative binding proteins. Her work focuses on advancing therapeutic options for various disorders.

Latest Patents

Deepali holds a patent for "Bispecific PD-1 and TIGIT binding proteins and uses thereof." This patent relates to binding proteins, including antibodies, that specifically bind to Programmed Death-1 (PD-1) and T cell immunoreceptor with Ig and ITIM domains (TIGIT). The disclosure encompasses compositions comprising such binding proteins and nucleic acid molecules encoding them. Furthermore, it outlines methods for treating disorders or conditions using these binding proteins. She has 1 patent to her name.

Career Highlights

Deepali is currently employed at MedImmune Limited, where she continues to push the boundaries of biopharmaceutical research. Her innovative approach and dedication to her work have positioned her as a key player in her field.

Collaborations

Throughout her career, Deepali has collaborated with notable colleagues, including Yariv Mazor and Yue Wang. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking therapies.

Conclusion

Deepali Malhotra's contributions to the field of biopharmaceuticals exemplify her commitment to innovation and research. Her work on bispecific binding proteins holds promise for advancing treatment options for various medical conditions.